Cochlear (ASX:COH) share price edges higher to break 52-week record

It’s been a great year so far for the hearing solutions company.
The post Cochlear (ASX:COH) share price edges higher to break 52-week record appeared first on The Motley Fool Australia. –

The Cochlear Limited (ASX: COH) share price has delivered a stellar performance so far in 2021.

Since the start of the year, the hearing solution company’s shares have continued on their upwards trajectory, gaining almost 30%.

However, today Cochlear shares reached an important milestone, breaking a new 52-week high of $244.62.

With no news released to the ASX today, let’s take a look at Cochlear’s most recent price-sensitive announcement.

What’s been pushing the Cochlear share price higher?

Investors have been buying up Cochlear shares over the last 6 months following the company’s positive February half-year results.

For the 6-month period, Cochlear reported sales revenue of $742.8 million, down 4% against the first half of FY20’s result. While this may appear disappointing, when looking closer, surgeries recovered towards the second quarter following the easing of COVID-19 shutdowns.

Sales revenue dropped 8% in the first quarter, but rebounded to edge 8% higher in the following 3 months (Q2 FY21). Cochlear attributed the performance to varying degrees of growth across established versus emerging international markets. The United States, Japan, South Korea, and China recorded robust sales, while India and Brazil struggled with volumes.

On the bottom line, the company posted an underlying net profit of $125.3 million, falling 6% against a COVID-free first-half period (H1 FY20). The result was driven by a solid recovery in sales revenue and lower operating expenses due to material COVID-related savings.

Cochlear is projecting it will achieve FY21 underlying net profit between $225 million and $245 million. This is a 46% to 59% increase on last year’s FY20 result.

The company noted that the deployment of COVID-19 vaccines, and rapid return of surgeries, is a positive sign for its resilient business.

Broker update

After reporting its first-half results, a number of brokers rated the company with varying price points. Investment firm, Macquarie raised its price target for Cochlear by 1.7% to $245.00. Morgan Stanley followed suit to also increase its rating by 6.1% to $227.00. The most recent broker note came from Credit Suisse in late May, which initiated a price of $225.00 for the hearing solutions company.

At today’s market close, the Cochlear share price had slightly retreated from its 52-week high to $243.46, up 0.58% for the day.

The post Cochlear (ASX:COH) share price edges higher to break 52-week record appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

4 buy-rated ASX shares for June

3 ASX shares for buy and hold investors to check out

Why ‘value’ and ‘growth’ share categories are meaningless

Why the Nanosonics (ASX:NAN) share price fell 8% in May
4 ASX 200 blue chip shares analysts rate as buys

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Cochlear Ltd. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!